The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
MMP9: A Tough Target for Targeted Therapy for Cancer
Open accessAbstract
Having the capability to proteolyze diverse structural and signaling proteins, matrix metalloproteinase 9 (MMP9), one of the best-studied secretory endopeptidases, has been identified as a crucial mediator of processes closely associated with tumorigenesis, such as the extracellular matrix reorganization, epithelial to mesenchymal transition, cell migration, new blood vessel formation, and immune response. In this review, we present the current state of knowledge on MMP9 and its role in cancer growth in the context of cell adhesion/migration, cancer-related inflammation, and tumor microenvironment formation. We also summarize recent achievements in the development of selective MMP9 inhibitors and the limitations of using them as anticancer drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Lakka, S. S., Gondi, C. S., Yanamandra, N., Olivero, W. C., Dinh, D. H., Gujrati, M., & Rao, J. S. (2004) · Oncogene · doi:10.1038/sj.onc.1207616 · Cited by 291
RetractedLakka, S. S., Jasti, S. L., Gondi, C. S., Boyd, D. B., Chandrasekar, N., Dinh, D. H., Olivero, W. C., Gujrati, M., & Rao, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205646 · Cited by 100
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Engineering precision nanoparticles for drug delivery
Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933
A framework for advancing our understanding of cancer-associated fibroblasts
Sahai, E., Astsaturov, I., Cukierman, E., DeNardo, D. G., Egeblad, M., Evans, R. M., Fearon, D., Greten, F. R., Hingorani, S. R., Hunter, T., et al. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0238-1 · Cited by 3,863 · cited 20×
“In this way, MMP9 regulates tissue remodeling, cell–cell and cell–ECM interactions, and activation of extracellular signal molecules, which promote cell migration, proliferation, angiogenesis, EMT, and ECM remodeling.”
BackgroundInfluentialMatrix metalloproteinases and their inhibitors in connective tissue remodeling
Woessner, J. F. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.8.1850705 · Cited by 3,282
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Extracellular Matrix Assembly: A Multiscale Deconstruction
Mouw, J. K., Ou, G., & Weaver, V. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3902 · Cited by 1,534 · cited 1×
“Tightly controlled changes in the extracellular network of macromolecules are known to contribute to the normal tissue development, inflammation, and wound healing but also fibrosis or cancer growth and invasion [65,66].”
BackgroundVan Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase
Kjeldsen, L., Johnsen, A. H., Sengeløv, H., & Borregaard, N. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82217-7 · Cited by 1,284
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Processing of tumour necrosis factor-α precursor by metalloproteinases
Gearing, A. J. H., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., et al. (1994) · Nature · doi:10.1038/370555a0 · Cited by 1,194
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Quintero-Fabián, S., Arreola, R., Becerril-Villanueva, E., Torres-Romero, J. C., Arana-Argáez, V., Lara-Riegos, J., Ramírez-Camacho, M. A., & Alvarez-Sánchez, M. E. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01370 · Cited by 1,036
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Transmembrane TNF- : structure, function and interaction with anti-TNF agents
Horiuchi, T., Mitoma, H., Harashima, S.-I., Tsukamoto, H., & Shimoda, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq031 · Cited by 864
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts
Ginestier, C., Liu, S., Diebel, M. E., Korkaya, H., Luo, M., Brown, M., Wicinski, J., Cabaud, O., Charafe-Jauffret, E., Birnbaum, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39397 · Cited by 747
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Sato, H., & Seiki, M. (1993) · PubMed · Cited by 695
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
Noë, V., Fingleton, B., Jacobs, K., Crawford, H. C., Vermeulen, S., Steelant, W., Bruyneel, E., Matrisian, L. M., & Mareel, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.1.111 · Cited by 695
Schönbeck, U., Mach, F., & Libby, P. (1998) · PubMed · Cited by 681
Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., & Opdenakker, G. (2000) · Blood · doi:10.1182/blood.v96.8.2673 · Cited by 680
Yan, L., Borregaard, N., Kjeldsen, L., & Moses, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106089200 · Cited by 676
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107736200 · Cited by 655
Ogata, Y., Enghild, J. J., & Nagase, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50563-4 · Cited by 627
McQuibban, G. A., Gong, J.-H., Wong, J. P., Wallace, J. L., Clark-Lewis, I., & Overall, C. M. (2002) · Blood · doi:10.1182/blood.v100.4.1160.h81602001160_1160_1167 · Cited by 611
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Schönbeck, U., Mach, F., & Libby, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3340 · Cited by 595
Ramos-DeSimone, N., Hahn-Dantona, E., Sipley, J., Nagase, H., French, D. L., & Quigley, J. P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13066 · Cited by 591
Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models
Fanjul-Fernández, M., Folgueras, A. R., Cabrera, S., & López-Otín, C. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.07.004 · Cited by 582
Van Lint, P., & Libert, C. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607338 · Cited by 564
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 559
Gelatinase B functions as regulator and effector in leukocyte biology
Opdenakker, G., Van den Steen, P. E., Dubois, B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., & Van Damme, J. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.851 · Cited by 553 · cited 1×
“In other cell types, MMP9 is synthesized de novo during stimulation induced with cytokines [32,33].”
BackgroundBond, M., Fabunmi, R. P., Baker, A. H., & Newby, A. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01034-5 · Cited by 512
Okamoto, T., Akaike, T., Sawa, T., Miyamoto, Y., van der Vliet, A., & Maeda, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102417200 · Cited by 468
Matrix metalloproteinases: Fold and function of their catalytic domains
Tallant, C., Marrero, A., & Gomis-Rüth, F. X. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.003 · Cited by 463
RNA interference: From gene silencing to gene-specific therapeutics
Leung, R. K. M., & Whittaker, P. A. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.03.004 · Cited by 382
Multifunctional intracellular matrix metalloproteinases: implications in disease
Bassiouni, W., Ali, M. A. M., & Schulz, R. (2021) · The FEBS Journal · doi:10.1111/febs.15701 · Cited by 377
Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z., & Damsky, C. H. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.3.867 · Cited by 374
Gallic acid: Molecular rival of cancer
Verma, S., Singh, A., & Mishra, A. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.02.011 · Cited by 368
Bond, M. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00220-6 · Cited by 366
Role of Cadherins in Cancer—A Review
Kaszak, I., Witkowska-Piłaszewicz, O., Niewiadomska, Z., Dworecka-Kaszak, B., Ngosa Toka, F., & Jurka, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207624 · Cited by 356
Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski-Oja, J., & Tryggvason, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55326-6 · Cited by 333
Cho, A., & Reidy, M. A. (2002) · Circulation Research · doi:10.1161/01.res.0000040420.17366.2e · Cited by 319
Belotti, D., Paganoni, P., Manenti, L., Garofalo, A., Marchini, S., Taraboletti, G., & Giavazzi, R. (2003) · PubMed · Cited by 318
Bekes, E. M., Schweighofer, B., Kupriyanova, T. A., Zajac, E., Ardi, V. C., Quigley, J. P., & Deryugina, E. I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.031 · Cited by 298
Midgley, A. C., Rogers, M., Hallett, M. B., Clayton, A., Bowen, T., Phillips, A. O., & Steadman, R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451336 · Cited by 296
Van den Steen, P. E., Wuyts, A., Husson, S. J., Proost, P., Van Damme, J., & Opdenakker, G. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03760.x · Cited by 288
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu, B., Hsu, S.-M., Ho, H., Lien, H., Huang, S., & Lin, R. H. (2001) · PubMed · Cited by 268
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Basement Membranes in Development and Disease
Sekiguchi, R., & Yamada, K. M. (2018) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.02.005 · Cited by 243
Symowicz, J., Adley, B. P., Gleason, K. J., Johnson, J. J., Ghosh, S., Fishman, D. A., Hudson, L. G., & Stack, M. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2808 · Cited by 235
Matrix metalloproteinases stimulate epithelial-mesenchymal transition during tumor development
Orlichenko, L. S., & Radisky, D. C. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9143-9 · Cited by 234
Matrix metalloproteinase-9 activates TGF-β and stimulates fibroblast contraction of collagen gels
Kobayashi, T., Kim, H., Liu, X., Sugiura, H., Kohyama, T., Fang, Q., Wen, F.-Q., Abe, S., Wang, X., Atkinson, J. J., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00015.2014 · Cited by 229
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Inoue, K., Slaton, J. W., Kim, S. J., Perrotte, P., Eve, B. Y., Bar‐Eli, M., Radinsky, R., & Dinney, C. P. (2000) · PubMed · Cited by 222
Marshall, D. C., Lyman, S. K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127063 · Cited by 201
Ellerbroek, S. M., Halbleib, J. M., Benavidez, M., Warmka, J. K., Wattenberg, E. V., Stack, M. S., & Hudson, L. G. (2001) · PubMed · Cited by 193
Substrate Hydrolysis by Matrix Metalloproteinase-9*
Kridel, S. J., Chen, E., Kotra, L. P., Howard, E. W., Mobashery, S., & Smith, J. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100900200 · Cited by 192
Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16518 · Cited by 189
Van den Steen, P. E., Van Aelst, I., Hvidberg, V., Piccard, H., Fiten, P., Jacobsen, C., Moestrup, S. K., Fry, S., Royle, L., Wormald, M. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512308200 · Cited by 189
Mañes, S., Llorente, M., Lacalle, R. A., Gómez-Moutón, C., Kremer, L., Mira, E., & Martı́nez-A, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.6935 · Cited by 188
Matrix Metalloproteinase-9 Deficiency Results in Enhanced Allergen-Induced Airway Inflammation
McMillan, S. J., Kearley, J., Campbell, J. D., Zhu, X.-W., Larbi, K. Y., Shipley, J. M., Senior, R. M., Nourshargh, S., & Lloyd, C. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2586 · Cited by 185
Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., Stack, M. S., & Hudson, L. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5046 · Cited by 182
New intracellular activities of matrix metalloproteinases shine in the moonlight
Jobin, P. G., Butler, G. S., & Overall, C. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.013 · Cited by 182
Kyriakides, T. R., Wulsin, D., Skokos, E. A., Fleckman, P., Pirrone, A., Shipley, J. M., Senior, R. M., & Bornstein, P. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.01.001 · Cited by 173
Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1
Ye, Y., Kuang, X., Xie, Z., Liang, L., Zhang, Z., Zhang, Y., Ma, F., Gao, Q., Chang, R., Lee, H., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00780-z · Cited by 171
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
Tai, K.-Y., Shieh, Y.-S., Lee, C.-S., Shiah, S.-G., & Wu, C.-W. (2008) · Oncogene · doi:10.1038/onc.2008.57 · Cited by 168
Role of Matrix Metalloproteinase-9 Dimers in Cell Migration
Dufour, A., Zucker, S., Sampson, N. S., Kuscu, C., & Cao, J. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.091769 · Cited by 166
Influence of IL-8 on The Epithelial–Mesenchymal Transition and the Tumor Microenvironment
Palena, C., Hamilton, D. H., & Fernando, R. I. (2012) · Future Oncology · doi:10.2217/fon.12.59 · Cited by 166
Activation of the 92-kDa Gelatinase by Stromelysin and 4-Aminophenylmercuric Acetate
Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M., & Welgus, H. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6351 · Cited by 165
Activity of matrix metalloproteinase‐9 against native collagen types I and III
Bigg, H. F., Rowan, A. D., Barker, M. D., & Cawston, T. E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05669.x · Cited by 162
Han, Y.-P., Tuan, T.-L., Hughes, M., Wu, H., & Garner, W. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010839200 · Cited by 161
Scannevin, R. H., Alexander, R., Haarlander, T. M., Burke, S. L., Singer, M., Huo, C., Zhang, Y.-M., Maguire, D., Spurlino, J., Deckman, I., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806075 · Cited by 160
Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
Christensen, J., & Shastri, V. P. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1284-8 · Cited by 159
Matrix metalloproteinases and their inhibitors in pulmonary hypertension
Chelladurai, P., Seeger, W., & Pullamsetti, S. S. (2012) · European Respiratory Journal · doi:10.1183/09031936.00209911 · Cited by 159
Thomas, G. J., Lewis, M. P., Hart, I. R., Marshall, J. F., & Speight, P. M. (2001) · International Journal of Cancer · Cited by 158
Bannikov, G. A., Karelina, T. V., Collier, I. E., Marmer, B. L., & Goldberg, G. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110931200 · Cited by 154
Characterization of the Monomeric and Dimeric Forms of Latent and Active Matrix Metalloproteinase-9
Olson, M. W., Bernardo, M. M., Pietila, M., Gervasi, D. C., Tóth, M., Kotra, L. P., Massova, I., Mobashery, S., & Fridman, R. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2661 · Cited by 149
Ye, J., Li, Y., Teruya, K., Katakura, Y., Ichikawa, A., Eto, H., Hosoi, M., Hosoi, M., Nishimoto, S., & Shirahata, S. (2005) · Cytotechnology · doi:10.1007/s10616-005-3761-8 · Cited by 146
Liu, P., & Wilson, M. J. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22993 · Cited by 145
Zinc‐Binding Groups Modulate Selective Inhibition of MMPs
Agrawal, A., Romero‐Perez, D., Jacobsen, J. A., Villarreal, F. J., & Cohen, S. M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700290 · Cited by 143
Mao, Z., Zhang, J., Shi, Y., Li, W., Shi, H., Ji, R., Mao, F., Qian, H., Xu, W., & Zhang, X. (2020) · Oncogenesis · doi:10.1038/s41389-020-00249-z · Cited by 142
Hanania, R., Sun, H., Xu, K., Pustylnik, S., Jeganathan, S., & Harrison, R. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290676 · Cited by 137
Nalla, A. K., Gorantla, B., Gondi, C. S., Lakka, S. S., & Rao, J. S. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.16 · Cited by 136
Structural Basis of the Adaptive Molecular Recognition by MMP9
Cha, H., Kopetzki, E., Huber, R., Lanzendörfer, M., & Brandstetter, H. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00558-2 · Cited by 132
TNF-α and IL-1β–mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells
Nee, L., McMorrow, T., Campbell, E. L., Slattery, C., & Ryan, M. P. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00900.x · Cited by 131
Dufour, A., Sampson, N. S., Li, J., Kuscu, C., Rizzo, R. C., DeLeon, J. L., Zhi, J., Jaber, N. L., Liu, E. V., Zucker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4552 · Cited by 131
The role of toll-like receptor 4 in tumor microenvironment
Li, J., Yang, F., Wei, F., & Ren, X. (2017) · Oncotarget · doi:10.18632/oncotarget.19105 · Cited by 131
Hong, S., Park, K., Magae, J., Ando, K., Lee, T., Kwon, T. K., Kwak, J., Kim, C., & Chang, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413985200 · Cited by 128
A Novel Transcriptional Repression Domain Mediates p21WAF1/CIP1 Induction of p300 Transactivation
Snowden, A. W., Anderson, L. A., Webster, G., & Perkins, N. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.8.2676-2686.2000 · Cited by 128
Antimetastatic Activity of a Novel Mechanism-Based Gelatinase Inhibitor
Krüger, A., Arlt, M., Gerg, M., Kopitz, C., Bernardo, M. M., Chang, M., Mobashery, S., & Fridman, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3570 · Cited by 127
Kim, K., Punj, V., Kim, J., Lee, S., Ulmer, T. S., Lu, W., Rice, J. C., & An, W. (2016) · Genes & Development · doi:10.1101/gad.268714.115 · Cited by 127
Sun, L., Diamond, M. E., Ottaviano, A. J., Joseph, M. J., Ananthanarayan, V., & Munshi, H. G. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0208 · Cited by 124
The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases
Tschesche, H., Zoelzer, V., Triebel, S., & Bartsch, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02066.x · Cited by 119
Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase
den Steen, P. E. V., Husson, S. J., Proost, P., Damme, J. V., & Opdenakker, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.098 · Cited by 118
Enhanced Syllable Discrimination Thresholds in Musicians
Zuk, J., Ozernov‐Palchik, O., Kim, H., Lakshminarayanan, K., Gabrieli, J. D. E., Tallal, P. A., & Gaab, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080546 · Cited by 117
Wolczyk, D., Zaremba-Czogalla, M., Hryniewicz-Jankowska, A., Tabola, R., Grabowski, K., Sikorski, A. F., & Augoff, K. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0280-x · Cited by 116
Self-citationOGAWA, K., CHEN, F., KUANG, C., & CHEN, Y. (2004) · Biochemical Journal · doi:10.1042/bj20040058 · Cited by 116
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
Owyong, M., Chou, J., van den Bijgaart, R. J. E., Kong, N., Efe, G., Maynard, C., Talmi-Frank, D., Solomonov, I., Koopman, C. D., Hadler‐Olsen, E., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201800226 · Cited by 115
The role of toll‐like receptor 4 (TLR4) in cancer progression: A possible therapeutic target?
Kashani, B., Zandi, Z., Pourbagheri‐Sigaroodi, A., Bashash, D., & Ghaffari, S. H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30166 · Cited by 114
Cox, J. H., Dean, R. A., Roberts, C. R., & Overall, C. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800266200 · Cited by 113
Abécassis, I., Olofsson, B., Schmid, M., Zalcman, G., & Karniguian, A. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.08.006 · Cited by 113
Involvement of CD44 in cytoskeleton rearrangement and raft reorganization in T cells
Föger, N., Marhaba, R., & Zöller, M. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.6.1169 · Cited by 112
Matrix Metalloproteinase-9 Functions as a Tumor Suppressor in Colitis-Associated Cancer
Garg, P., Sarma, D. S. R., Jeppsson, S., Patel, N. R., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3166 · Cited by 107
Dayer, C., & Stamenkovic, I. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.622274 · Cited by 106
Roeb, E., Schleinkofer, K., Kernebeck, T., Pötsch, S., Jansen, B., Behrmann, I., Matern, S., & Grötzinger, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207446200 · Cited by 106
Abdulkhalek, S., Amith, S. R., Franchuk, S. L., Jayanth, P., Guo, M., Finlay, T. M., Gilmour, A. M., Guzzo, C., Gee, K., Beyaert, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237578 · Cited by 101
Appleby, T. C., Greenstein, A. E., Hung, M., Liclican, A. C., Velasquez, M., Villaseñor, A. G., Wang, R., Wong, M. H. L., Liu, X., Papalia, G. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760579 · Cited by 101
Inflammation Induced by MMP-9 Enhances Tumor Regression of Experimental Breast Cancer
Leifler, K. S., Svensson, S., Abrahamsson, A. E., Bendrik, C., Robertson, J. V., Gauldie, J., Olsson, A., & Dabrosin, C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202610 · Cited by 100
Grijalvo, S., Puras, G., Sesma, J. Z., Sainz-Ramos, M., Qtaish, N. A., López-Méndez, T. B., Mashal, M., Attia, N., Díaz, D. D., Pons, R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020050 · Cited by 99
Chiu, P.-S., & Lai, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053370 · Cited by 97
Shah, M. A., Starodub, A., Sharma, S., Berlin, J. D., Patel, M., Wainberg, Z. A., Chaves, J. M., Gordon, M. S., Windsor, K. S., Brachmann, C. B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2469 · Cited by 97
MMP9 protects against LPS-induced inflammation in osteoblasts
Zhang, H., Liu, L., Jiang, C., Pan, K., Deng, J., & Wan, C. (2019) · Innate Immunity · doi:10.1177/1753425919887236 · Cited by 97
Challenges in Matrix Metalloproteinases Inhibition
Laronha, H., Carpinteiro, I., Portugal, J., Azul, A. M., Polido, M., Petrova, K. T., Salema‐Oom, M., & Caldeira, J. (2020) · Biomolecules · doi:10.3390/biom10050717 · Cited by 97
Bonfil, R. D., Sabbota, A. L., Nabha, S. M., Bernardo, M. M., Dong, Z., Hong, M., Yamamoto, H., Chinni, S. R., Lim, I. T., Chang, M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21645 · Cited by 95
Gilmour, A. M., Abdulkhalek, S., Cheng, T. S. W., Alghamdi, F., Jayanth, P., O'Shea, L., Geen, O. D., Arvizu, L. A., & Szewczuk, M. R. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.08.008 · Cited by 95
Martens, E., Leyssen, A., Aelst, I. V., Fiten, P., Piccard, H., Hu, J., Descamps, F. J., den Steen, P. E. V., Proost, P., Damme, J. V., et al. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.10.012 · Cited by 93
Lin, C., Kuo, C., Cheng, C., Wu, C.-Y., Lee, C., Hsieh, H., Lee, I., & Yang, C. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.07.002 · Cited by 93
Paemen, L. R., Martens, E., Masure, S., & Opdenakker, G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.759_a.x · Cited by 92
MMP-9 Sheds the β2 Integrin Subunit (CD18) from Macrophages
Vaisar, T., Kassim, S. Y., Gomez, I. G., Green, P. S., Hargarten, S., Gough, P. J., Parks, W. C., Wilson, C. L., Raines, E. W., & Heinecke, J. W. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800449-mcp200 · Cited by 91
Xia, Y., Lian, S., Khoi, P. N., Yoon, H. J., Joo, Y., Chay, K.-O., Kim, K. K., & Jung, Y. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124007 · Cited by 91
Rosenblum, G., Meroueh, S. O., Tóth, M., Fisher, J. F., Fridman, R. A., Mobashery, S., & Sagi, I. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073941l · Cited by 89
Cheng, C., Hsieh, H., Hsiao, L., & Yang, C. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.02.005 · Cited by 88
A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes
Alghamdi, F., Guo, M., Abdulkhalek, S., Crawford, N., Amith, S. R., & Szewczuk, M. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.015 · Cited by 87
Direct Visualization of Protease Action on Collagen Triple Helical Structure
Rosenblum, G., den Steen, P. E. V., Cohen, S., Bitler, A., Brand, D. D., Opdenakker, G., & Sagi, I. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011043 · Cited by 85
The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer.
Kuefer, R., Hofer, M. D., Gschwend, J. E., Pienta, K. J., Sanda, M. G., Chinnaiyan, A. M., Rubin, M. A., & Day, M. L. (2003) · PubMed · Cited by 84
Gene Transfer of Matrix Metalloproteinase-9 Induces Tumor Regression of Breast CancerIn vivo
Bendrik, C., Robertson, J. V., Gauldie, J., & Dabrosin, C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0295 · Cited by 80
Kim, H., Kim, H., Park, K., Kim, Y.-N., Kwon, T., Park, J., Lee, K.-U., Kim, J., & Lee, I. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.12 · Cited by 79
Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter
He, C. S. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04318-2 · Cited by 76
Latent MMP-9 is bound to TIMP-1 before secretion
Roderfeld, M., Graf, J., Giese, B., Salguero-Palacios, R., Tschuschner, A., Müller‐Newen, G., & Roeb, E. (2007) · Biological Chemistry · doi:10.1515/bc.2007.123 · Cited by 75
Jayanth, P., Amith, S. R., Gee, K., & Szewczuk, M. R. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.011 · Cited by 75
Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer
Li, Y., He, J., Wang, F., Wang, X., Yang, F., Zhao, C., Feng, C., & Li, T. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-01958-w · Cited by 75
Sato, F., Shimada, Y., Watanabe, G., Uchida, S., Makino, T., & Imamura, M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690530 · Cited by 74
Sindhu, S. T. A. K., Al-Roub, A., Koshy, M., Thomas, R., & Ahmad, R. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447798 · Cited by 73
Exosomes: natural nanoparticles as bio shuttles for RNAi delivery
Darband, S. G., Mirza‐Aghazadeh‐Attari, M., Kaviani, M., Mihanfar, A., Sadighparvar, S., Yousefi, B., & Majidinia, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.001 · Cited by 73
Soluble E-Cadherin is an Independent Pretherapeutic Factor for Long-Term Survival in Gastric Cancer
Chan, A. O., Chu, K., Lam, S., Wong, B. C., Kwok, K., Law, S. Y.-K., Ko, S., Hui, W., Yueng, Y., & Wong, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.078 · Cited by 72
Kim, Y. H., Kwon, H., & Kim, D. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357863 · Cited by 70
Lagarrigue, F., Dupuis-Coronas, S., Ramel, D., Delsol, G., Tronchère, H., Payrastre, B., & Gaits‐Iacovoni, F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0861 · Cited by 69
Al–Sadi, R., Youssef, M., Rawat, M., Guo, S., Dokładny, K., Haque, M., Watterson, D. M., & Ma, T. Y. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00126.2018 · Cited by 69
Epigenetic regulation of mmp-9 gene expression
Labrie, M., & St‐Pierre, Y. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1214-z · Cited by 67
Zhou, M., Zhang, Y., Ardans, J. A., & Wahl, L. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309075200 · Cited by 67
MMP Inhibitors Past present and future
Cao, J. P. (2015) · Frontiers in bioscience · doi:10.2741/4365 · Cited by 66
Kim, S., Kim, S. H., Hur, S. M., Lee, S.-K., Kim, W. W., Kim, J. S., Kim, J., Choe, J., Nam, S. J., Lee, J. E., et al. (2009) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2009.08.032 · Cited by 63
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma
Wang, T., Zhang, Y., Bai, J., Xue, Y., & Peng, Q. (2021) · BMC Cancer · doi:10.1186/s12885-021-08788-3 · Cited by 61
Synthesis of Chiral 2-(4-Phenoxyphenylsulfonylmethyl)thiiranes as Selective Gelatinase Inhibitors
Lee, M., Bernardo, M. M., Meroueh, S. O., Brown, S., Fridman, R. A., & Mobashery, S. (2005) · Organic Letters · doi:10.1021/ol0517269 · Cited by 59
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels
Coticchia, C. M., Curatolo, A. S., Zurakowski, D., Yang, J., Daniels, K. E., Matulonis, U. A., & Moses, M. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.07.034 · Cited by 59
Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis
Shchors, K., Nozawa, H., Xu, J., Rostker, F., Swigart, L. B., Evan, G. I., & Hanahan, D. (2012) · Oncogene · doi:10.1038/onc.2012.60 · Cited by 59
Kalva, S., Singam, E. R. A., Rajapandian, V., Saleena, L. M., & Subramanian, V. (2014) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.12.008 · Cited by 57
Chen, Y., & Chang, L. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200167 · Cited by 56
Zhao, X., & Benveniste, E. N. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.08.071 · Cited by 55
Qiu, W., Zhang, H.-B., Xia, W., Ke, L., Yang, J., Yu, Y.-H., Hu, L., Huang, X.-J., Liu, G., Li, W., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0722-6 · Cited by 55
Gao, H., Lan, X., Li, S., & Xue, Y. (2017) · Tumor Biology · doi:10.1177/1010428317698368 · Cited by 54
Ma, Z., Chang, M. J., Shah, R. C., & Benveniste, E. N. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205112 · Cited by 53
Cáceres, L. C., Bonacci, G., Sanchez, M. C., & Chiabrando, G. A. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22737 · Cited by 52
Prognostic impact of MMP‐2 and MMP‐9 expression in pathologic stage IA non‐small cell lung cancer
Shao, W., Wang, W., Xiong, X., Cao, C. Q., Yan, T. D., Chen, G., Chen, H., Yin, W., Liu, J., Gu, Y., et al. (2011) · Journal of Surgical Oncology · doi:10.1002/jso.22001 · Cited by 51
Relevance of matrix metalloproteases in non-small cell lung cancer diagnosis
Blanco-Prieto, S., Barcia-Castro, L., de la Cadena, M. P., Rodrı́guez-Berrocal, F. J., Vázquez‐Iglesias, L., Botana-Rial, M. I., Fernández‐Villar, A., & Chiara, L. D. (2017) · BMC Cancer · doi:10.1186/s12885-017-3842-z · Cited by 51
Chen, X.-C., Wei, X., Guan, J., Shu, H., & Chen, D. (2017) · Oncotarget · doi:10.18632/oncotarget.19622 · Cited by 50
Harris, J. E., Fernandez‐Vilaseca, M., Elkington, P. T., Horncastle, D. E., Graeber, M. B., & Friedland, J. S. (2006) · The FASEB Journal · doi:10.1096/fj.06-6925com · Cited by 49
Gomez, I. G., Tang, J., Wilson, C. L., Yan, W., Heinecke, J. W., Harlan, J. M., & Raines, E. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.321182 · Cited by 49
Bai, X., Li, Y., Zhang, H., Wang, F., He, H., Yao, J.-C., Liu, L., & Li, S. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s134813 · Cited by 49
Alford, V. M., Kamath, A., Ren, X., Kumar, K., Gan, Q., Awwa, M., Tong, M., Seeliger, M. A., Cao, J. P., Ojima, I., et al. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00758 · Cited by 48
Ultrasound-mediated microbubble destruction: a new method in cancer immunotherapy
Tu, J., Zhang, H., Yu, J., Liufu, C., & Chen, Z. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s171019 · Cited by 46
Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells
Gu, X., Niu, J., Dorahy, D. J., Scott, R. J., & Agrez, M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600480 · Cited by 45
Dour, G. L., Moroy, G., Rouffet, M., Bourguet, E., Guillaume, D. M., Decarme, M., Mourabit, H. E., Augé, F., Alix, A. J. P., Laronze, J., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.07.041 · Cited by 41
N-Glycosylation pattern of the zymogenic form of human matrix metalloproteinase-9
Kotra, L. P., Zhang, L., Fridman, R. A., Orlando, R., & Mobashery, S. (2002) · Bioorganic Chemistry · doi:10.1016/s0045-2068(02)00501-1 · Cited by 38
Matrix metalloproteinase‐2 mediates ribosomal RNA transcription by cleaving nucleolar histones
Ali, M. A., Garcia‐Vilas, J. A., Cromwell, C. R., Hubbard, B. P., Hendzel, M. J., & Schulz, R. (2021) · FEBS Journal · doi:10.1111/febs.16061 · Cited by 36
Peltonen, R., Hagström, J., Tervahartiala, T. I., Sorsa, T. A., Haglund, C. H., & Isoniemi, H. (2020) · Oncology · doi:10.1159/000510609 · Cited by 35
Nguyen, J., Knapnougel, P., Lesavre, P., & Bauvois, B. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.012 · Cited by 34
Walter, L., Pujada, A., Bhatnagar, N., Bialkowska, A. B., Yang, V. W., Laroui, H., & Garg, P. (2016) · Oncotarget · doi:10.18632/oncotarget.13406 · Cited by 34
The role of polarisation of circulating tumour cells in cancer metastasis
Heikenwälder, M. F., & Lorentzen, A. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03169-3 · Cited by 33
Thieringer, F. R., Maass, T., Anthon, B., Meyer, E., Schirmacher, P., Longerich, T., Galle, P. R., Kanzler, S., & Teufel, A. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20809 · Cited by 32
Meisel, J. E., & Chang, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.011 · Cited by 32
Awasthi, N., Mikels, A. J., Stefanutti, E., Schwarz, M. A., Monahan, S., Smith, V., & Schwarz, R. E. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14242 · Cited by 32
Functional Roles of N‐Linked Glycosylation of Human Matrix Metalloproteinase 9
Duellman, T., Burnett, J., & Yang, J. (2015) · Traffic · doi:10.1111/tra.12312 · Cited by 30
Zhang, Z., Amorosa, L. F., Coyle, S. M., Macor, M., Lubitz, S. E., Carson, J. L., Birnbaum, M. J., Lee, L. Y., & Haimovich, B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500944 · Cited by 30
Zaremba-Czogalla, M., Hryniewicz‐Jankowska, A., Taboła, R., Nienartowicz, M., Stach, K., Wierzbicki, J., Cirocchi, R., Ziolkowski, P. P., Tabaczar, S., & Augoff, K. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.010 · Cited by 30
Self-citationEatock, M. M., Cassidy, J., Johnson, J. L., Morrison, R. A., Devlin, M., Blackey, R., Owen, S., Choi, L., & Twelves, C. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0856-4 · Cited by 29
Martins, L. M., Dourado, C. S. D. M. E., Campos-Verdes, L. M., Sampaio, F. A., Revoredo, C. M. S., Costa-Silva, D. R., Barros-Oliveira, M. D. C., Júnior, E. D. J. N., do Rego-Medeiros, L. M., Gebrim, L. H., et al. (2019) · Oncotarget · doi:10.18632/oncotarget.27347 · Cited by 27
INTERLEUKIN-8 (IL-8) EXPRESSION REGULATES TUMORIGENICITY AND METASTASIS IN HUMAN BLADDER CANCER
Inoue, K., Slaton, J. W., Perrotte, P., Eve, B. Y., & Dinney, C. P. (1999) · The Journal of Urology · doi:10.1097/00005392-199904010-00483 · Cited by 24
Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells
Nakabayashi, H., Yawata, T., & Shimizu, K. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-339 · Cited by 20
Role of N-glycosylation in activation of proMMP-9. A molecular dynamics simulations study
Kumar, S., & Cieplak, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191157 · Cited by 12
Metadata
- Authors
- Augoff, K., Hryniewicz-Jankowska, A., Tabola, R., & Stach, K.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2022-04-06
- Volume
- 14
- Issue
- 7
- Pages
- 1847
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W4223515068
- Cited by
- 255
- References
- 186
- FWCI
- 17.49
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.